2020 Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status (pilot)

Scheme description
Distribution of DNA from chronic lymphocytic leukaemia samples for IGHV mutation status
Disorders/Gene target(s)
Chronic Lymphocytic Leukaemia (CLL)
Clinical cases
Three
Testing/analysis
IGHV mutation status
Sample type
DNA in TE buffer
Techniques
Any
Assessment
Eligibility
Any ERIC certified laboratory for IGHV testing
Languages
English
ISO17043 Accredited EQA
No
EQA timeline
Sample dispatchTo be confirmed
Testing period5 weeks
Assessment resultsTo be confirmed
Final Summary reportNot applicable.
Other information
In collaboration with UK NEQAS LI. Submissions will be assessed against ERIC recommendations.
Fee
£100.00
GenQA code
2020CLLIGHV
« Return to EQA scheme list
Go to top